| Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months (NCT05252715) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2021-12-18 |
| Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents (NCT05087056) | GlaxoSmithKline | 2021-11-18 |
| Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans (NCT04685850) | Centre Hospitalier Intercommunal Creteil | 2021-07-09 |
| A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults (NCT04665791) | Center for Vaccine Development - Mali | 2021-03-02 |
| Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine (NCT04707391) | GlaxoSmithKline | 2021-01-25 |
| A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine (NCT04689191) | Wei Cun | 2020-09-15 |
| A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine (NCT04689165) | Wei Cun | 2020-09-14 |
| Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018 (NCT03431675) | Epicentre | 2019-03-01 |
| Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population (NCT03682939) | St George's, University of London | 2019-02-21 |
| Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months (NCT05229536) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2018-12-21 |
| A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age (NCT03433482) | GlaxoSmithKline | 2018-08-30 |
| Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years (NCT03587207) | GlaxoSmithKline | 2018-07-09 |
| High and Low Resource Interventions to Promote HPV Vaccines (NCT03824093) | Children's Mercy Hospital Kansas City | 2018-07-01 |
| A Sourcing Study to Collect Human Blood Samples From Healthy Adults (NCT03493919) | GlaxoSmithKline | 2018-03-08 |
| Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds (NCT03295318) | Serum Institute of India Pvt. Ltd. | 2017-11-15 |
| Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA. (NCT03378258) | Belfast Health and Social Care Trust | 2017-11-09 |
| Ciprofloxacin for the Prevention of Meningococcal Meningitis (NCT02724046) | Epicentre | 2017-04-22 |
| A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14 (NCT03549325) | University Hospital Southampton NHS Foundation Trust | 2017-03-13 |
| Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers (NCT03205371) | Sanofi Pasteur, a Sanofi Company | 2016-11-07 |
| Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months (NCT02878291) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2016-06-01 |
| A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years (NCT01352793) | Pfizer | 2012-11-01 |
| Study Evaluating Safety And Tolerability Of Meningococcal B Rlp2086 Vaccine In Healthy Adults (NCT00879814) | Pfizer | 2009-04-01 |
| A Study Evaluating Safety And Immunogenicity Of Meningococcal B Rlp2086 Vaccine In Adolescents (NCT00808028) | Pfizer | 2009-02-01 |
| Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants (NCT00798304) | Pfizer | 2009-01-01 |
| Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults (NCT00780806) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants (NCT00474526) | Novartis Vaccines | 2007-03-01 |
| RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) (NCT00443846) | Merck Sharp & Dohme LLC | 2007-02-13 |
| Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults (NCT00297687) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-03-01 |
| Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants (NCT00161928) | Pfizer | 2002-04-01 |
| Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants (NCT00314041) | Wyeth is now a wholly owned subsidiary of Pfizer | 1997-06-01 |